Key elements of metabolomics in the study of biomarkers of diabetes
Metabolomics is instrumental in the analysis of disease mechanisms and biomarkers of disease. The human metabolome is influenced by genetics and environmental interactions and reveals characteristic signatures of disease. Population studies with metabolomics require special study designs and care ne...
Gespeichert in:
| Veröffentlicht in: | Diabetologia 2016-12, Vol.59 (12), p.2497-2502 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2502 |
|---|---|
| container_issue | 12 |
| container_start_page | 2497 |
| container_title | Diabetologia |
| container_volume | 59 |
| creator | Adamski, Jerzy |
| description | Metabolomics is instrumental in the analysis of disease mechanisms and biomarkers of disease. The human metabolome is influenced by genetics and environmental interactions and reveals characteristic signatures of disease. Population studies with metabolomics require special study designs and care needs to be taken with pre-analytics. Gas chromatography coupled to mass spectrometry, liquid chromatography coupled to mass spectrometry or NMR are popular techniques used for metabolomic analyses in human cohorts. Metabolomics has been successfully used in the biomarker search for disease prediction and progression, for analyses of drug action and for the development of companion diagnostics. Several metabolites or metabolite classes identified by metabolomics have gained much attention in the field of diabetes research in the search for early disease detection, differentiation of progressor types and compliance with medication. This review summarises a presentation given at the ‘New approaches beyond genetics’ symposium at the 2015 annual meeting of the EASD. It is accompanied by another review from this symposium by Bernd Mayer (DOI:
10.1007/s00125-016-4032-2
) and an overview by the Session Chair, Leif Groop (DOI:
10.1007/s00125-016-4014-4
). |
| doi_str_mv | 10.1007/s00125-016-4044-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1846413024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835406395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-1044d25d29df56c27e97aa6a7210d4c18afeab057ac92c4f0e6ee381716c8f063</originalsourceid><addsrcrecordid>eNqNkUtLxDAUhYMozvj4AW6k4MZN9d40TdqlDL5wwI2Cu5Cmt9qxj7FpF_33po6KCIKrLM53z809h7EjhDMEUOcOAHkcAspQgBDhuMXmKCIeguDJNptPcoiJfJqxPedWABDFQu6yGVcKhRByzhZ3NAZUUU1N74K2CGrqTdZWbV1aF5RN0L9Q4PohHycxK9vadK_UfaB5aTLqyR2wncJUjg4_3332eHX5sLgJl_fXt4uLZWhjFH2I_os5j3Oe5kUsLVeUKmOkURwhFxYTU5DJIFbGptyKAkgSRQkqlDYpQEb77HTju-7at4Fcr-vSWaoq01A7OI2JkAIj4OIfqE_CW6axR09-oat26Bp_yEQpAJFC5CncULZrneuo0Ouu9FmMGkFPZehNGdqXoacy9Ohnjj-dh6ym_HviK30P8A3gvNQ8U_dj9Z-u7_PckyE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837004903</pqid></control><display><type>article</type><title>Key elements of metabolomics in the study of biomarkers of diabetes</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Adamski, Jerzy</creator><creatorcontrib>Adamski, Jerzy</creatorcontrib><description>Metabolomics is instrumental in the analysis of disease mechanisms and biomarkers of disease. The human metabolome is influenced by genetics and environmental interactions and reveals characteristic signatures of disease. Population studies with metabolomics require special study designs and care needs to be taken with pre-analytics. Gas chromatography coupled to mass spectrometry, liquid chromatography coupled to mass spectrometry or NMR are popular techniques used for metabolomic analyses in human cohorts. Metabolomics has been successfully used in the biomarker search for disease prediction and progression, for analyses of drug action and for the development of companion diagnostics. Several metabolites or metabolite classes identified by metabolomics have gained much attention in the field of diabetes research in the search for early disease detection, differentiation of progressor types and compliance with medication. This review summarises a presentation given at the ‘New approaches beyond genetics’ symposium at the 2015 annual meeting of the EASD. It is accompanied by another review from this symposium by Bernd Mayer (DOI:
10.1007/s00125-016-4032-2
) and an overview by the Session Chair, Leif Groop (DOI:
10.1007/s00125-016-4014-4
).</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-016-4044-y</identifier><identifier>PMID: 27714446</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Biomarkers - metabolism ; Diabetes Mellitus - metabolism ; Female ; Human Physiology ; Humans ; Internal Medicine ; Magnetic Resonance Spectroscopy ; Male ; Mass Spectrometry ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Metabolomics - methods ; Mini-Review</subject><ispartof>Diabetologia, 2016-12, Vol.59 (12), p.2497-2502</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-1044d25d29df56c27e97aa6a7210d4c18afeab057ac92c4f0e6ee381716c8f063</citedby><cites>FETCH-LOGICAL-c514t-1044d25d29df56c27e97aa6a7210d4c18afeab057ac92c4f0e6ee381716c8f063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-016-4044-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-016-4044-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>313,314,780,784,792,27922,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27714446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adamski, Jerzy</creatorcontrib><title>Key elements of metabolomics in the study of biomarkers of diabetes</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Metabolomics is instrumental in the analysis of disease mechanisms and biomarkers of disease. The human metabolome is influenced by genetics and environmental interactions and reveals characteristic signatures of disease. Population studies with metabolomics require special study designs and care needs to be taken with pre-analytics. Gas chromatography coupled to mass spectrometry, liquid chromatography coupled to mass spectrometry or NMR are popular techniques used for metabolomic analyses in human cohorts. Metabolomics has been successfully used in the biomarker search for disease prediction and progression, for analyses of drug action and for the development of companion diagnostics. Several metabolites or metabolite classes identified by metabolomics have gained much attention in the field of diabetes research in the search for early disease detection, differentiation of progressor types and compliance with medication. This review summarises a presentation given at the ‘New approaches beyond genetics’ symposium at the 2015 annual meeting of the EASD. It is accompanied by another review from this symposium by Bernd Mayer (DOI:
10.1007/s00125-016-4032-2
) and an overview by the Session Chair, Leif Groop (DOI:
10.1007/s00125-016-4014-4
).</description><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Female</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Metabolomics - methods</subject><subject>Mini-Review</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkUtLxDAUhYMozvj4AW6k4MZN9d40TdqlDL5wwI2Cu5Cmt9qxj7FpF_33po6KCIKrLM53z809h7EjhDMEUOcOAHkcAspQgBDhuMXmKCIeguDJNptPcoiJfJqxPedWABDFQu6yGVcKhRByzhZ3NAZUUU1N74K2CGrqTdZWbV1aF5RN0L9Q4PohHycxK9vadK_UfaB5aTLqyR2wncJUjg4_3332eHX5sLgJl_fXt4uLZWhjFH2I_os5j3Oe5kUsLVeUKmOkURwhFxYTU5DJIFbGptyKAkgSRQkqlDYpQEb77HTju-7at4Fcr-vSWaoq01A7OI2JkAIj4OIfqE_CW6axR09-oat26Bp_yEQpAJFC5CncULZrneuo0Ouu9FmMGkFPZehNGdqXoacy9Ohnjj-dh6ym_HviK30P8A3gvNQ8U_dj9Z-u7_PckyE</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Adamski, Jerzy</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20161201</creationdate><title>Key elements of metabolomics in the study of biomarkers of diabetes</title><author>Adamski, Jerzy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-1044d25d29df56c27e97aa6a7210d4c18afeab057ac92c4f0e6ee381716c8f063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Female</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Metabolomics - methods</topic><topic>Mini-Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adamski, Jerzy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adamski, Jerzy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Key elements of metabolomics in the study of biomarkers of diabetes</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>59</volume><issue>12</issue><spage>2497</spage><epage>2502</epage><pages>2497-2502</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Metabolomics is instrumental in the analysis of disease mechanisms and biomarkers of disease. The human metabolome is influenced by genetics and environmental interactions and reveals characteristic signatures of disease. Population studies with metabolomics require special study designs and care needs to be taken with pre-analytics. Gas chromatography coupled to mass spectrometry, liquid chromatography coupled to mass spectrometry or NMR are popular techniques used for metabolomic analyses in human cohorts. Metabolomics has been successfully used in the biomarker search for disease prediction and progression, for analyses of drug action and for the development of companion diagnostics. Several metabolites or metabolite classes identified by metabolomics have gained much attention in the field of diabetes research in the search for early disease detection, differentiation of progressor types and compliance with medication. This review summarises a presentation given at the ‘New approaches beyond genetics’ symposium at the 2015 annual meeting of the EASD. It is accompanied by another review from this symposium by Bernd Mayer (DOI:
10.1007/s00125-016-4032-2
) and an overview by the Session Chair, Leif Groop (DOI:
10.1007/s00125-016-4014-4
).</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27714446</pmid><doi>10.1007/s00125-016-4044-y</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-186X |
| ispartof | Diabetologia, 2016-12, Vol.59 (12), p.2497-2502 |
| issn | 0012-186X 1432-0428 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1846413024 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Animals Biomarkers - metabolism Diabetes Mellitus - metabolism Female Human Physiology Humans Internal Medicine Magnetic Resonance Spectroscopy Male Mass Spectrometry Medicine Medicine & Public Health Metabolic Diseases Metabolomics - methods Mini-Review |
| title | Key elements of metabolomics in the study of biomarkers of diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A00%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Key%20elements%20of%20metabolomics%20in%20the%20study%20of%20biomarkers%20of%20diabetes&rft.jtitle=Diabetologia&rft.au=Adamski,%20Jerzy&rft.date=2016-12-01&rft.volume=59&rft.issue=12&rft.spage=2497&rft.epage=2502&rft.pages=2497-2502&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-016-4044-y&rft_dat=%3Cproquest_cross%3E1835406395%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837004903&rft_id=info:pmid/27714446&rfr_iscdi=true |